Science
Scientific validation for verified research peptides
A batch-first quality system built around identity confirmation, purity profiling, COA visibility, and clear Research Use Only restrictions.
Evidence has to travel with the vial.
Product specs, COA language, and release criteria use the same verifiable facts so qualified buyers can identify what Lyos Labs actually controls.
Purity analysis
RP-HPLC
RP-HPLC purity analysis is performed by Kovera Labs before a compound is released to the catalog.
Purity profile
>= 98%
Peak-area integration and chromatographic traces are reviewed against compound-specific release limits.
Residual solvents
Reviewed
Residual solvent risk is assessed during release review and documented with lot records where applicable.
Lot traceability
COA-linked
Each vial is mapped to batch documentation, handling notes, and fulfillment records.
Use restriction
RUO only
Products are supplied only for qualified in-vitro research and are not for human or veterinary use.
ANALYTICAL WORKFLOW
Verification
before visibility.
The storefront should not make a researcher hunt for trust signals. Every step is written in plain, citable language and tied to the batch release path.
Synthesis review
Sequence assembly, raw material identity, and coupling efficiency are reviewed before purification begins.
Purification and identity
HPLC purification isolates the target compound. RP-HPLC purity analysis is then performed by Kovera Labs before release.
Lyophilized finish
Controlled drying produces stable research material with storage guidance tied to the lot record.
Release documentation
COA records, lot numbers, purity data, and RUO terms remain visible through the buyer journey.
EVIDENCE ARCHITECTURE
Clear facts beat
decorative claims.
Researchers should be able to answer qualification questions without interpreting brand language. The same facts appear in headings, release criteria, and FAQ answers.
Certificate of Analysis
Batch-specific release documentation gives researchers a single reference for identity, purity, lot number, and storage expectations.
Analytical traceability
Chromatographic evidence and mass-confirmation language are structured so institutional teams can audit quickly.
Compliance language
Research Use Only restrictions are repeated at the page, product, cart, and checkout levels to reduce ambiguity.
Direct answers for qualification and audit.
These answers are intentionally visible so institutional buyers receive the same compliant language wherever they enter the page.
How does Lyos Labs verify peptide identity?
Lyos Labs uses batch-level analytical review with RP-HPLC purity analysis by Kovera Labs before release to the storefront.
What does a peptide COA include?
A Lyos Labs COA is designed to carry the lot number, compound identity, purity profile, storage guidance, and research-use restriction for institutional documentation.
Are Lyos Labs compounds intended for human use?
No. Lyos Labs supplies research peptides for qualified in-vitro research only. Products are not for human consumption, veterinary use, diagnosis, treatment, or clinical application.
How are storage requirements documented?
Lot-specific storage expectations are documented on the COA or release record supplied for the material. Lyos Labs does not publish public preparation, reconstitution, dosing, administration, or human-use instructions.